GPT and Cholecystitis: Meanwhile, patients with an elevated BMI (p = 0.026, OR = 1.014, 95% CI [1.002, 1.027]), elevated ALT levels (p <0.001, OR = 1.113, 95% CI [1.062, 1.166]), elevated lipase levels (p = 0.003, OR = 1.003, 95% CI [1.001, 1.005]), and a diagnosis of cholecystitis (p < 0.001, OR = 15.720, 95% CI [12.534, 19.715]) are more likely to undergo ERCP than patients with a lower BMI, lower ALT levels, lower lipase levels, or patients without a diagnosis of cholecystitis (Table 4).